Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

B B Rewari

Biographic Data

ID8929678
NAMEB B Rewari
GIVEN NAMESB B
FAMILY NAMERewari
SIGNATUREREWARI B B
AFFILIATIONSMinistry of Health and Family Welfare
VERIFIEDNo
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2015
LATEST PUBLICATION YEAR2016
H-INDEX0
  • Parental concerns on disclosure of HIV status to children living with HIV

    G N Sanjeeva, H B Pavithra et al.•ARTICLE•AIDS Care•2016

    Disclosure is an important component of comprehensive management of children living with HIV infection (CLHIV). Many parental concerns are barriers for disclosure in children and only few studies addresses children's perspective on these concerns. Our study aims to understand children's perspective on parental concerns for disclosure and assess the knowledge of HIV. A questionnaire-based cross-sectional study involving CLHIV between 10 and 18 yea…

  • Nevirapine-related adverse events among children switched from efavirenz to nevirapine as compared to children who were started on nevirapine-based antiretroviral therapy directly

    G N Sanjeeva, V Sukanya et al.•ARTICLE•AIDS Care•2015

    In this retrospective study, incidence of nevirapine (NVP) toxicity in children who were switched from efavirenz (EFV) to NVP (treatment experienced [TE] group) was compared with that of children who had started NVP-based antiretroviral therapy directly (treatment naïve [TN] group). This study also identified risk factors associated with development of NVP toxicity in children. The incidence and risk of developing NVP toxicities were significantl…

No prominent works on this page.

  • Nevirapine-related adverse events among children switched from efavirenz to nevirapine as compared to children who were started on nevirapine-based antiretroviral therapy directly

    G N Sanjeeva, V Sukanya et al.•ARTICLE•AIDS Care•2015

    In this retrospective study, incidence of nevirapine (NVP) toxicity in children who were switched from efavirenz (EFV) to NVP (treatment experienced [TE] group) was compared with that of children who had started NVP-based antiretroviral therapy directly (treatment naïve [TN] group). This study also identified risk factors associated with development of NVP toxicity in children. The incidence and risk of developing NVP toxicities were significantl…

  • Parental concerns on disclosure of HIV status to children living with HIV

    G N Sanjeeva, H B Pavithra et al.•ARTICLE•AIDS Care•2016

    Disclosure is an important component of comprehensive management of children living with HIV infection (CLHIV). Many parental concerns are barriers for disclosure in children and only few studies addresses children's perspective on these concerns. Our study aims to understand children's perspective on parental concerns for disclosure and assess the knowledge of HIV. A questionnaire-based cross-sectional study involving CLHIV between 10 and 18 yea…

HIV/AIDS Research and Interventions (2 works) · Medicine (2 works) · Adolescent Sexual and Reproductive Health (1 work) · Adverse effect (1 work) · Alternative medicine (1 work) · Antiretroviral therapy (1 work) · Clinical Psychology (1 work) · Efavirenz (1 work) · Family medicine (1 work) · HIV Research and Treatment (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae